Jonathan Lim
Chairman and CEO
Chairman
CEO
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Erasca, Inc. (ERAS) | Chairman, Chief Executive Officer, and Co-Founder | $670,400 | $4,298,838 |
| 2024 | Erasca, Inc. (ERAS) | Chairman, Chief Executive Officer, and Co-Founder | $644,600 | $3,894,032 |
| 2023 | Erasca, Inc. (ERAS) | Chairman, Chief Executive Officer, and Co-Founder | $622,800 | $5,407,446 |
| 2022 | Erasca, Inc. (ERAS) | Chairman, Chief Executive Officer, and Co-Founder | $593,100 | $7,523,335 |
| 2021 | Erasca, Inc. (ERAS) | Chairman and Chief Executive Officer | $497,846 | $850,234 |
| 2020 | Erasca, Inc. (ERAS) | Chairman and Chief Executive Officer | $300,000 | $1,964,696 |
Earnings-call appearances
-
Erasca, Inc. Q4 FY2023 Earnings Call2024-03-27
Erasca, Inc. (ERAS)
-
Alnylam Pharmaceuticals, Inc. Q3 FY2020 Earnings Call2020-11-05
Alnylam Pharmaceuticals, Inc. (ALNY)